← Evidence map

ReviewClinical rheumatology2015

Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?

Torsten WittePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25604317